Clinical Research
Log in
Clinical Research Details
Back to List
Descriptive Information
Title
An Open-Label, Single-Arm Study To Evaluate The Effectiveness And Safety Of Ocrelizumab In Patients With Early Stage Relapsing Remitting Multiple Sclerosis
Investigator Name
Bassem Yamout
Email
yamoutba@gmail.com
Protocol Id
MA30143
Status
Recruiting
Study Type
Clinical Research
-
Clinical Trials (phase 0, 1,2 3 & 4)
Phase
Phase 3
Looking for Med Students Volunteers
No
Collaborators
Samia Khoury
Nabil El Ayoubi
Marwa Baalbaki
Maya Zeineddine
Lina Abdul-Latif Malaeb
Joelle Massouh
Wassim Assaad
Mayssam El Najjar
Coordinators
Cynthia Eid
ce32@aub.edu.lb
Extension: 7436
Conditions and Keywords
Conditions
multiple sclerosis
Keywords
Ocrelizumab,RRMS
Study Design
Primary Purpose
Treatment
Classification
Safety and/or Efficacy Study
Time Perspective
Prospective
Masking
Open Label
Intervention Model
Single Group
Allocation
N/A: Single arm study
Observational Study Model
N/A: Not Applicable
Eligibility and IRB
Gender
Both
Age Limits
Min:
18
Max:
55
IRB Approval
Yes
Healthy Volunteer
No
Study Description
Population Description
Sampling Method
Inclusion Criteria
Exclusion Criteria
Back to List
